FDA.reportPublic FDA data

168 HR BuTrans 0.02 MG/HR Transdermal System

RxCUI
904878
RxNorm name
168 HR BuTrans 0.02 MG/HR Transdermal System
Display name
168 HR BuTrans 0.02 MG/HR Transdermal System
Full name
168 HR BuTrans 0.02 MG/HR Transdermal System
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ButransBUPRENORPHINEKnoa Pharma LLC794aa355-66de-41b8-aedf-f2c40f6bc6642026-05-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 904878

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
794aa355-66de-41b8-aedf-f2c40f6bc664Butrans 20 MCG/HR 7 Day Transdermal System [PSN] · 168 HR buprenorphine 0.02 MG/HR Transdermal System [BuTrans] [SBD] · 168 HR BuTrans 0.02 MG/HR Transdermal System [SY] · Butrans 20 MCG/HR 7 Day Transdermal Patch [SY] · Butrans 20 MCG/HR 7 Day Transdermal System [SY]532These highlights do not include all the information needed to use BUTRANS ® safely and effectively. See full prescribing information for BUTRANS. BUTRANS ® (buprenorphine) transdermal system, CIII Initial U.S. Approval: 198120260501